Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Margin

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 14.7414.1716.3910.6516.58

What is the latest Core EBITDA Margin ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Margin ratio of ASTRAZENECA PHARMA INDIA is 14.74 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar202514.74
Mar202414.17
Mar202316.39
Mar202210.65
Mar202116.58

How is Core EBITDA Margin of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Margin % Change
Mar2025 14.74
4.02
Mar2024 14.17
-13.54
Mar2023 16.39
53.90
Mar2022 10.65
-35.77
Mar2021 16.58 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Margin ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹22,955.8 Cr 4% 1.8% 32.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

4%

1.8%

32.9%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses